ASX:AYAHealth Care Equipment & ServicesHealth Care Technology
ARTRYA ORD
$2.780
$0.280 (9.15%)
Day Range
$2.750 - $2.980
52 Week Range
$0.560 - $5.240
Volume
816.71K
Avg Volume (10D)
417.56K
Market Cap
$439.47M
Price Chart
Market Statistics
Open$2.980
Previous Close$3.060
Day High$2.980
Day Low$2.750
52 Week High$5.240
52 Week Low$0.560
Valuation
Market Cap439.47M
Shares Outstanding158.08M
Price to Book5.45
Trading Activity
Volume816.71K
Value Traded2.32M
Bid$2.780 × 107
Ask$2.900 × 10,000
Performance
1 Day-1.28%
5 Day-8.61%
13 Week-21.23%
52 Week313.42%
YTD-34.61%
Technical Indicators
RSI (14)37.60
50-Day SMA$3.535
200-Day SMA$2.628
Latest News
Biotechnology
Artrya Secures Second US Commercial Order for Salix SaaS Platform to Manage Coronary Artery Disease
Artrya (ASX: AYA) has signed a commercial agreement with US-based Northeast Georgia Health System for the use of its Salix AI cloud platform for point-of-care assessment and management of coronary artery disease.
1 min read
Biotechnology
Artrya Wins FDA Clearance to Advance Rollout of Salix Coronary Plaque Module
Artrya (ASX: AYA) has received clearance from the US Food and Drug Administration for its Salix Coronary Plaque module. The regulatory milestone enables the company to charge per-scan fees in its largest market, significantly enhancing revenue potential. The approval follows Artrya’s recent US launch and builds on momentum established with its Salix Coronary Anatomy platform. […]
3 min read
